Woman holding and using digital tablet global network connection

Featured News

MRIGlobal, Biomérieux, Epipointe, and Synertex Sign Data Use Agreement for Trends Software to Research Infectious Diseases

Data sharing enhances potential to form unique private-public partnerships

MRIGlobal, bioMérieux, EpiPointe LLC, and Synertex LLC have signed a data use agreement which permits access to an aggregated, de-identified pathogen detection data from connected BioFire® FilmArray® Systems in the United States. The permitted use of BioFire® Syndromic Trends (Trend) data is to evaluate current methods through retrospective studies, public health applications, and to aid efforts to identify epidemiological trends through research and development (R&D). This data sharing resource among partners will serve as a “hypothesis incubator” to further explore pathogen circulation trends information compiled in near real time.

Trend is a software feature from BioFire®, a bioMérieux company, that provides local and regional pathogen circulation trends on demand. Users can view pathogen trends for their lab as well as regional and national pathogen trends, all of which are created from de-identified data that has been aggregated with other participating institutions’ test data.

“This unique partnership builds long-standing relationships related to R&D, clinical diagnostics and infectious disease surveillance and reinforces collaborations across multi-sector networks,” said MRIGlobal’s Kenny Yeh, Senior Director.

As experts in infectious disease research and development, and testing, MRIGlobal’s experts and partners are dedicated to continued efforts to enhance research and development in the areas of public health preparedness and related biosurveillance.